Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this clinical trial are to compare the quality of life of the subjects, the
efficacy and the tolerance of Duac® Gel (gel formulation with a combination of clindamycin
phosphate [equivalent to 1% clindamycin] and 5% benzoyl peroxide), applied once daily,
against Differin® Gel (gel with 0.1% adapalene), used once daily, in the treatment of mild to
moderate acne vulgaris.